{
  "version": "https://jsonfeed.org/version/1.1",
  "title": "PeptideScanner Human Evidence Review changes",
  "home_page_url": "https://peptidescanner.com/synthesis/changes/",
  "feed_url": "https://peptidescanner.com/feeds/synthesis.json",
  "description": "Approved review versions and attributed publisher notices for PeptideScanner Human Evidence Reviews.",
  "items": [
    {
      "id": "living-review-afamelanotide-v1-published",
      "url": "https://peptidescanner.com/peptides/afamelanotide/synthesis/versions/1/",
      "title": "Afamelanotide Human Evidence Review version 1",
      "content_text": "PeptideScanner published bounded review version 1 from 4 explicitly reviewed source snapshots.",
      "date_published": "2026-09-15T00:00:00.000Z",
      "_peptidescanner": {
        "id": "living-review-afamelanotide-v1-published",
        "kind": "review-version-published",
        "peptideSlug": "afamelanotide",
        "peptideName": "Afamelanotide",
        "version": 1,
        "changedAt": "2026-09-15",
        "integrityCheckedAt": null,
        "sourceChangedAt": null,
        "title": "Afamelanotide Human Evidence Review version 1",
        "summary": "PeptideScanner published bounded review version 1 from 4 explicitly reviewed source snapshots.",
        "href": "/peptides/afamelanotide/synthesis/versions/1/",
        "citations": [
          {
            "authority": "PubMed",
            "recordId": "26132941",
            "title": "Afamelanotide for Erythropoietic Protoporphyria.",
            "url": "https://pubmed.ncbi.nlm.nih.gov/26132941/"
          },
          {
            "authority": "PubMed",
            "recordId": "40082741",
            "title": "German Cohort Observational Study to Investigate the Short- and Long-Term Safety and Clinical Effectiveness of Afamelanotide 16 mg (SCENESSE) in Patients With Erythropoietic Protoporphyria (EPP).",
            "url": "https://pubmed.ncbi.nlm.nih.gov/40082741/"
          },
          {
            "authority": "PubMed",
            "recordId": "25230094",
            "title": "Afamelanotide and narrowband UV-B phototherapy for the treatment of vitiligo: a randomized multicenter trial.",
            "url": "https://pubmed.ncbi.nlm.nih.gov/25230094/"
          },
          {
            "authority": "PubMed",
            "recordId": "37496004",
            "title": "A feasibility and safety study of afamelanotide in acute stroke patients - an open label, proof of concept, phase iia clinical trial.",
            "url": "https://pubmed.ncbi.nlm.nih.gov/37496004/"
          }
        ]
      }
    },
    {
      "id": "living-review-amycretin-v1-published",
      "url": "https://peptidescanner.com/peptides/amycretin/synthesis/versions/1/",
      "title": "Amycretin Human Evidence Review version 1",
      "content_text": "PeptideScanner published bounded review version 1 from 4 explicitly reviewed source snapshots.",
      "date_published": "2026-09-15T00:00:00.000Z",
      "_peptidescanner": {
        "id": "living-review-amycretin-v1-published",
        "kind": "review-version-published",
        "peptideSlug": "amycretin",
        "peptideName": "Amycretin",
        "version": 1,
        "changedAt": "2026-09-15",
        "integrityCheckedAt": null,
        "sourceChangedAt": null,
        "title": "Amycretin Human Evidence Review version 1",
        "summary": "PeptideScanner published bounded review version 1 from 4 explicitly reviewed source snapshots.",
        "href": "/peptides/amycretin/synthesis/versions/1/",
        "citations": [
          {
            "authority": "PubMed",
            "recordId": "40550229",
            "title": "Safety, tolerability, pharmacokinetics, and pharmacodynamics of the first-in-class GLP-1 and amylin receptor agonist, amycretin: a first-in-human, phase 1, double-blind, randomised, placebo-controlled trial.",
            "url": "https://pubmed.ncbi.nlm.nih.gov/40550229/"
          },
          {
            "authority": "PubMed",
            "recordId": "40550231",
            "title": "Amycretin, a novel, unimolecular GLP-1 and amylin receptor agonist administered subcutaneously: results from a phase 1b/2a randomised controlled study.",
            "url": "https://pubmed.ncbi.nlm.nih.gov/40550231/"
          },
          {
            "authority": "PubMed",
            "recordId": "42532079",
            "title": "Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.",
            "url": "https://pubmed.ncbi.nlm.nih.gov/42532079/"
          },
          {
            "authority": "PubMed",
            "recordId": "42532080",
            "title": "Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.",
            "url": "https://pubmed.ncbi.nlm.nih.gov/42532080/"
          }
        ]
      }
    },
    {
      "id": "living-review-amycretin-v2-published",
      "url": "https://peptidescanner.com/peptides/amycretin/synthesis/versions/2/",
      "title": "Amycretin Human Evidence Review version 2",
      "content_text": "PeptideScanner published bounded review version 2 from 5 explicitly reviewed source snapshots.",
      "date_published": "2026-09-15T00:00:00.000Z",
      "_peptidescanner": {
        "id": "living-review-amycretin-v2-published",
        "kind": "review-version-published",
        "peptideSlug": "amycretin",
        "peptideName": "Amycretin",
        "version": 2,
        "changedAt": "2026-09-15",
        "integrityCheckedAt": null,
        "sourceChangedAt": null,
        "title": "Amycretin Human Evidence Review version 2",
        "summary": "PeptideScanner published bounded review version 2 from 5 explicitly reviewed source snapshots.",
        "href": "/peptides/amycretin/synthesis/versions/2/",
        "citations": [
          {
            "authority": "PubMed",
            "recordId": "40550229",
            "title": "Safety, tolerability, pharmacokinetics, and pharmacodynamics of the first-in-class GLP-1 and amylin receptor agonist, amycretin: a first-in-human, phase 1, double-blind, randomised, placebo-controlled trial.",
            "url": "https://pubmed.ncbi.nlm.nih.gov/40550229/"
          },
          {
            "authority": "PubMed",
            "recordId": "40550231",
            "title": "Amycretin, a novel, unimolecular GLP-1 and amylin receptor agonist administered subcutaneously: results from a phase 1b/2a randomised controlled study.",
            "url": "https://pubmed.ncbi.nlm.nih.gov/40550231/"
          },
          {
            "authority": "PubMed",
            "recordId": "42532079",
            "title": "Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.",
            "url": "https://pubmed.ncbi.nlm.nih.gov/42532079/"
          },
          {
            "authority": "PubMed",
            "recordId": "42532080",
            "title": "Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.",
            "url": "https://pubmed.ncbi.nlm.nih.gov/42532080/"
          },
          {
            "authority": "PubMed",
            "recordId": "42443140",
            "title": "Renal Impairment Does Not Affect Pharmacokinetics, Safety or Tolerability of Zenagamtide.",
            "url": "https://pubmed.ncbi.nlm.nih.gov/42443140/"
          }
        ]
      }
    },
    {
      "id": "living-review-bremelanotide-v1-published",
      "url": "https://peptidescanner.com/peptides/bremelanotide/synthesis/versions/1/",
      "title": "Bremelanotide Human Evidence Review version 1",
      "content_text": "PeptideScanner published bounded review version 1 from 3 explicitly reviewed source snapshots.",
      "date_published": "2026-09-15T00:00:00.000Z",
      "_peptidescanner": {
        "id": "living-review-bremelanotide-v1-published",
        "kind": "review-version-published",
        "peptideSlug": "bremelanotide",
        "peptideName": "Bremelanotide",
        "version": 1,
        "changedAt": "2026-09-15",
        "integrityCheckedAt": null,
        "sourceChangedAt": null,
        "title": "Bremelanotide Human Evidence Review version 1",
        "summary": "PeptideScanner published bounded review version 1 from 3 explicitly reviewed source snapshots.",
        "href": "/peptides/bremelanotide/synthesis/versions/1/",
        "citations": [
          {
            "authority": "PubMed",
            "recordId": "31599840",
            "title": "Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials.",
            "url": "https://pubmed.ncbi.nlm.nih.gov/31599840/"
          },
          {
            "authority": "PubMed",
            "recordId": "35147466",
            "title": "Safety Profile of Bremelanotide Across the Clinical Development Program.",
            "url": "https://pubmed.ncbi.nlm.nih.gov/35147466/"
          },
          {
            "authority": "PubMed",
            "recordId": "27181790",
            "title": "Bremelanotide for female sexual dysfunctions in premenopausal women: a randomized, placebo-controlled dose-finding trial.",
            "url": "https://pubmed.ncbi.nlm.nih.gov/27181790/"
          }
        ]
      }
    },
    {
      "id": "living-review-cagrilintide-notice-010f7f064b21dabb-registered",
      "url": "https://peptidescanner.com/peptides/cagrilintide/synthesis/versions/2/#synthesis-pubmed-42251859-v2",
      "title": "Erratum connected to the Cagrilintide review",
      "content_text": "The reviewed Crossref snapshot attributes this erratum notice to publisher metadata. It is not a PeptideScanner correction.",
      "date_published": "2026-09-15T00:00:00.000Z",
      "_peptidescanner": {
        "id": "living-review-cagrilintide-notice-010f7f064b21dabb-registered",
        "kind": "publisher-notice-registered",
        "peptideSlug": "cagrilintide",
        "peptideName": "Cagrilintide",
        "version": 2,
        "changedAt": "2026-09-15",
        "integrityCheckedAt": "2026-09-15",
        "sourceChangedAt": "2026-08-01",
        "title": "Erratum connected to the Cagrilintide review",
        "summary": "The reviewed Crossref snapshot attributes this erratum notice to publisher metadata. It is not a PeptideScanner correction.",
        "href": "/peptides/cagrilintide/synthesis/versions/2/#synthesis-pubmed-42251859-v2",
        "citations": [
          {
            "authority": "PubMed",
            "recordId": "42251859",
            "title": "Cagrilintide-semaglutide (CagriSema) versus semaglutide or cagrilintide in people with type 2 diabetes (REIMAGINE 2): a double-blind, randomised, controlled, phase 3 study.",
            "url": "https://pubmed.ncbi.nlm.nih.gov/42251859/"
          },
          {
            "authority": "Crossref",
            "recordId": "10.1016/s2213-8587(26)00125-7",
            "title": "Crossref integrity metadata for PMID 42251859",
            "url": "https://api.crossref.org/works/10.1016%2Fs2213-8587(26)00125-7"
          },
          {
            "authority": "DOI",
            "recordId": "10.1016/s2213-8587(26)00157-9",
            "title": "Erratum",
            "url": "https://doi.org/10.1016/s2213-8587(26)00157-9"
          }
        ]
      }
    },
    {
      "id": "living-review-cagrilintide-v2-published",
      "url": "https://peptidescanner.com/peptides/cagrilintide/synthesis/versions/2/",
      "title": "Cagrilintide Human Evidence Review version 2",
      "content_text": "PeptideScanner published bounded review version 2 from 6 explicitly reviewed source snapshots.",
      "date_published": "2026-09-15T00:00:00.000Z",
      "_peptidescanner": {
        "id": "living-review-cagrilintide-v2-published",
        "kind": "review-version-published",
        "peptideSlug": "cagrilintide",
        "peptideName": "Cagrilintide",
        "version": 2,
        "changedAt": "2026-09-15",
        "integrityCheckedAt": null,
        "sourceChangedAt": null,
        "title": "Cagrilintide Human Evidence Review version 2",
        "summary": "PeptideScanner published bounded review version 2 from 6 explicitly reviewed source snapshots.",
        "href": "/peptides/cagrilintide/synthesis/versions/2/",
        "citations": [
          {
            "authority": "PubMed",
            "recordId": "34798060",
            "title": "Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial",
            "url": "https://pubmed.ncbi.nlm.nih.gov/34798060/"
          },
          {
            "authority": "PubMed",
            "recordId": "40544433",
            "title": "Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity.",
            "url": "https://pubmed.ncbi.nlm.nih.gov/40544433/"
          },
          {
            "authority": "PubMed",
            "recordId": "40544432",
            "title": "Cagrilintide-Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes.",
            "url": "https://pubmed.ncbi.nlm.nih.gov/40544432/"
          },
          {
            "authority": "PubMed",
            "recordId": "42251860",
            "title": "Efficacy and safety of once-weekly cagrilintide-semaglutide (CagriSema) in adults with type 2 diabetes inadequately controlled on diet and exercise (REIMAGINE 1): a randomised, double-blind, placebo-controlled, phase 3a study.",
            "url": "https://pubmed.ncbi.nlm.nih.gov/42251860/"
          },
          {
            "authority": "PubMed",
            "recordId": "42251859",
            "title": "Cagrilintide-semaglutide (CagriSema) versus semaglutide or cagrilintide in people with type 2 diabetes (REIMAGINE 2): a double-blind, randomised, controlled, phase 3 study.",
            "url": "https://pubmed.ncbi.nlm.nih.gov/42251859/"
          },
          {
            "authority": "PubMed",
            "recordId": "42251856",
            "title": "Cagrilintide-semaglutide (CagriSema) as an add-on to basal insulin in adults with type 2 diabetes (REIMAGINE 3): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study.",
            "url": "https://pubmed.ncbi.nlm.nih.gov/42251856/"
          }
        ]
      }
    },
    {
      "id": "living-review-cjc-1295-v1-published",
      "url": "https://peptidescanner.com/peptides/cjc-1295/synthesis/versions/1/",
      "title": "CJC-1295 Human Evidence Review version 1",
      "content_text": "PeptideScanner published bounded review version 1 from 2 explicitly reviewed source snapshots.",
      "date_published": "2026-09-15T00:00:00.000Z",
      "_peptidescanner": {
        "id": "living-review-cjc-1295-v1-published",
        "kind": "review-version-published",
        "peptideSlug": "cjc-1295",
        "peptideName": "CJC-1295",
        "version": 1,
        "changedAt": "2026-09-15",
        "integrityCheckedAt": null,
        "sourceChangedAt": null,
        "title": "CJC-1295 Human Evidence Review version 1",
        "summary": "PeptideScanner published bounded review version 1 from 2 explicitly reviewed source snapshots.",
        "href": "/peptides/cjc-1295/synthesis/versions/1/",
        "citations": [
          {
            "authority": "PubMed",
            "recordId": "16352683",
            "title": "Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults.",
            "url": "https://pubmed.ncbi.nlm.nih.gov/16352683/"
          },
          {
            "authority": "PubMed",
            "recordId": "17018654",
            "title": "Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog.",
            "url": "https://pubmed.ncbi.nlm.nih.gov/17018654/"
          }
        ]
      }
    },
    {
      "id": "living-review-cjc-1295-v2-published",
      "url": "https://peptidescanner.com/peptides/cjc-1295/synthesis/versions/2/",
      "title": "CJC-1295 Human Evidence Review version 2",
      "content_text": "PeptideScanner published bounded review version 2 from 3 explicitly reviewed source snapshots.",
      "date_published": "2026-09-15T00:00:00.000Z",
      "_peptidescanner": {
        "id": "living-review-cjc-1295-v2-published",
        "kind": "review-version-published",
        "peptideSlug": "cjc-1295",
        "peptideName": "CJC-1295",
        "version": 2,
        "changedAt": "2026-09-15",
        "integrityCheckedAt": null,
        "sourceChangedAt": null,
        "title": "CJC-1295 Human Evidence Review version 2",
        "summary": "PeptideScanner published bounded review version 2 from 3 explicitly reviewed source snapshots.",
        "href": "/peptides/cjc-1295/synthesis/versions/2/",
        "citations": [
          {
            "authority": "PubMed",
            "recordId": "16352683",
            "title": "Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults.",
            "url": "https://pubmed.ncbi.nlm.nih.gov/16352683/"
          },
          {
            "authority": "PubMed",
            "recordId": "17018654",
            "title": "Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog.",
            "url": "https://pubmed.ncbi.nlm.nih.gov/17018654/"
          },
          {
            "authority": "PubMed",
            "recordId": "19386527",
            "title": "Activation of the GH/IGF-1 axis by CJC-1295, a long-acting GHRH analog, results in serum protein profile changes in normal adult subjects.",
            "url": "https://pubmed.ncbi.nlm.nih.gov/19386527/"
          }
        ]
      }
    },
    {
      "id": "living-review-dulaglutide-v1-published",
      "url": "https://peptidescanner.com/peptides/dulaglutide/synthesis/versions/1/",
      "title": "Dulaglutide Human Evidence Review version 1",
      "content_text": "PeptideScanner published bounded review version 1 from 3 explicitly reviewed source snapshots.",
      "date_published": "2026-09-15T00:00:00.000Z",
      "_peptidescanner": {
        "id": "living-review-dulaglutide-v1-published",
        "kind": "review-version-published",
        "peptideSlug": "dulaglutide",
        "peptideName": "Dulaglutide",
        "version": 1,
        "changedAt": "2026-09-15",
        "integrityCheckedAt": null,
        "sourceChangedAt": null,
        "title": "Dulaglutide Human Evidence Review version 1",
        "summary": "PeptideScanner published bounded review version 1 from 3 explicitly reviewed source snapshots.",
        "href": "/peptides/dulaglutide/synthesis/versions/1/",
        "citations": [
          {
            "authority": "PubMed",
            "recordId": "31189511",
            "title": "Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.",
            "url": "https://pubmed.ncbi.nlm.nih.gov/31189511/"
          },
          {
            "authority": "PubMed",
            "recordId": "35658022",
            "title": "Once-Weekly Dulaglutide for the Treatment of Youths with Type 2 Diabetes.",
            "url": "https://pubmed.ncbi.nlm.nih.gov/35658022/"
          },
          {
            "authority": "PubMed",
            "recordId": "29910024",
            "title": "Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial.",
            "url": "https://pubmed.ncbi.nlm.nih.gov/29910024/"
          }
        ]
      }
    },
    {
      "id": "living-review-elamipretide-v1-published",
      "url": "https://peptidescanner.com/peptides/elamipretide/synthesis/versions/1/",
      "title": "Elamipretide Human Evidence Review version 1",
      "content_text": "PeptideScanner published bounded review version 1 from 3 explicitly reviewed source snapshots.",
      "date_published": "2026-09-15T00:00:00.000Z",
      "_peptidescanner": {
        "id": "living-review-elamipretide-v1-published",
        "kind": "review-version-published",
        "peptideSlug": "elamipretide",
        "peptideName": "Elamipretide",
        "version": 1,
        "changedAt": "2026-09-15",
        "integrityCheckedAt": null,
        "sourceChangedAt": null,
        "title": "Elamipretide Human Evidence Review version 1",
        "summary": "PeptideScanner published bounded review version 1 from 3 explicitly reviewed source snapshots.",
        "href": "/peptides/elamipretide/synthesis/versions/1/",
        "citations": [
          {
            "authority": "PubMed",
            "recordId": "33077895",
            "title": "A phase 2/3 randomized clinical trial followed by an open-label extension to evaluate the effectiveness of elamipretide in Barth syndrome, a genetic disorder of mitochondrial cardiolipin metabolism.",
            "url": "https://pubmed.ncbi.nlm.nih.gov/33077895/"
          },
          {
            "authority": "PubMed",
            "recordId": "38602181",
            "title": "Long-term efficacy and safety of elamipretide in patients with Barth syndrome: 168-week open-label extension results of TAZPOWER.",
            "url": "https://pubmed.ncbi.nlm.nih.gov/38602181/"
          },
          {
            "authority": "PubMed",
            "recordId": "37268435",
            "title": "Efficacy and Safety of Elamipretide in Individuals With Primary Mitochondrial Myopathy: The MMPOWER-3 Randomized Clinical Trial.",
            "url": "https://pubmed.ncbi.nlm.nih.gov/37268435/"
          }
        ]
      }
    },
    {
      "id": "living-review-emideltide-v1-published",
      "url": "https://peptidescanner.com/peptides/emideltide/synthesis/versions/1/",
      "title": "Emideltide Human Evidence Review version 1",
      "content_text": "PeptideScanner published bounded review version 1 from 2 explicitly reviewed source snapshots.",
      "date_published": "2026-09-15T00:00:00.000Z",
      "_peptidescanner": {
        "id": "living-review-emideltide-v1-published",
        "kind": "review-version-published",
        "peptideSlug": "emideltide",
        "peptideName": "Emideltide",
        "version": 1,
        "changedAt": "2026-09-15",
        "integrityCheckedAt": null,
        "sourceChangedAt": null,
        "title": "Emideltide Human Evidence Review version 1",
        "summary": "PeptideScanner published bounded review version 1 from 2 explicitly reviewed source snapshots.",
        "href": "/peptides/emideltide/synthesis/versions/1/",
        "citations": [
          {
            "authority": "PubMed",
            "recordId": "1299794",
            "title": "Effects of delta sleep-inducing peptide on sleep of chronic insomniac patients. A double-blind study.",
            "url": "https://pubmed.ncbi.nlm.nih.gov/1299794/"
          },
          {
            "authority": "PubMed",
            "recordId": "3622582",
            "title": "Effects of delta-sleep-inducing peptide on 24-hour sleep-wake behaviour in severe chronic insomnia.",
            "url": "https://pubmed.ncbi.nlm.nih.gov/3622582/"
          }
        ]
      }
    },
    {
      "id": "living-review-epitalon-v1-published",
      "url": "https://peptidescanner.com/peptides/epitalon/synthesis/versions/1/",
      "title": "Epitalon Human Evidence Review version 1",
      "content_text": "PeptideScanner published bounded review version 1 from 2 explicitly reviewed source snapshots.",
      "date_published": "2026-09-15T00:00:00.000Z",
      "_peptidescanner": {
        "id": "living-review-epitalon-v1-published",
        "kind": "review-version-published",
        "peptideSlug": "epitalon",
        "peptideName": "Epitalon",
        "version": 1,
        "changedAt": "2026-09-15",
        "integrityCheckedAt": null,
        "sourceChangedAt": null,
        "title": "Epitalon Human Evidence Review version 1",
        "summary": "PeptideScanner published bounded review version 1 from 2 explicitly reviewed source snapshots.",
        "href": "/peptides/epitalon/synthesis/versions/1/",
        "citations": [
          {
            "authority": "PubMed",
            "recordId": "12195242",
            "title": "Pineal-regulating tetrapeptide epitalon improves eye retina condition in retinitis pigmentosa.",
            "url": "https://pubmed.ncbi.nlm.nih.gov/12195242/"
          },
          {
            "authority": "PubMed",
            "recordId": "33280326",
            "title": "[AEDG peptide regulates human circadian rhythms genes expression during pineal gland accelerated aging.].",
            "url": "https://pubmed.ncbi.nlm.nih.gov/33280326/"
          }
        ]
      }
    },
    {
      "id": "living-review-ghk-cu-v1-published",
      "url": "https://peptidescanner.com/peptides/ghk-cu/synthesis/versions/1/",
      "title": "GHK-Cu Human Evidence Review version 1",
      "content_text": "PeptideScanner published bounded review version 1 from 3 explicitly reviewed source snapshots.",
      "date_published": "2026-09-15T00:00:00.000Z",
      "_peptidescanner": {
        "id": "living-review-ghk-cu-v1-published",
        "kind": "review-version-published",
        "peptideSlug": "ghk-cu",
        "peptideName": "GHK-Cu",
        "version": 1,
        "changedAt": "2026-09-15",
        "integrityCheckedAt": null,
        "sourceChangedAt": null,
        "title": "GHK-Cu Human Evidence Review version 1",
        "summary": "PeptideScanner published bounded review version 1 from 3 explicitly reviewed source snapshots.",
        "href": "/peptides/ghk-cu/synthesis/versions/1/",
        "citations": [
          {
            "authority": "PubMed",
            "recordId": "17147644",
            "title": "Enhanced healing of ulcers in patients with diabetes by topical treatment with glycyl-l-histidyl-l-lysine copper.",
            "url": "https://pubmed.ncbi.nlm.nih.gov/17147644/"
          },
          {
            "authority": "PubMed",
            "recordId": "16847171",
            "title": "Effects of topical copper tripeptide complex on CO2 laser-resurfaced skin.",
            "url": "https://pubmed.ncbi.nlm.nih.gov/16847171/"
          },
          {
            "authority": "PubMed",
            "recordId": "29482481",
            "title": "Intradermal injections of a hair growth factor formulation for enhancement of human hair regrowth - safety and efficacy evaluation in a first-in-man pilot clinical study.",
            "url": "https://pubmed.ncbi.nlm.nih.gov/29482481/"
          }
        ]
      }
    },
    {
      "id": "living-review-glucagon-v1-published",
      "url": "https://peptidescanner.com/peptides/glucagon/synthesis/versions/1/",
      "title": "Glucagon Human Evidence Review version 1",
      "content_text": "PeptideScanner published bounded review version 1 from 3 explicitly reviewed source snapshots.",
      "date_published": "2026-09-15T00:00:00.000Z",
      "_peptidescanner": {
        "id": "living-review-glucagon-v1-published",
        "kind": "review-version-published",
        "peptideSlug": "glucagon",
        "peptideName": "Glucagon",
        "version": 1,
        "changedAt": "2026-09-15",
        "integrityCheckedAt": null,
        "sourceChangedAt": null,
        "title": "Glucagon Human Evidence Review version 1",
        "summary": "PeptideScanner published bounded review version 1 from 3 explicitly reviewed source snapshots.",
        "href": "/peptides/glucagon/synthesis/versions/1/",
        "citations": [
          {
            "authority": "PubMed",
            "recordId": "32514794",
            "title": "Glucagon Administration by Nasal and Intramuscular Routes in Adults With Type 1 Diabetes During Insulin-Induced Hypoglycaemia: A Randomised, Open-Label, Crossover Study.",
            "url": "https://pubmed.ncbi.nlm.nih.gov/32514794/"
          },
          {
            "authority": "PubMed",
            "recordId": "34620618",
            "title": "Comparison of a ready-to-use liquid glucagon injection administered by autoinjector to glucagon emergency kit for the symptomatic relief of severe hypoglycemia: two randomized crossover non-inferiority studies.",
            "url": "https://pubmed.ncbi.nlm.nih.gov/34620618/"
          },
          {
            "authority": "PubMed",
            "recordId": "29504662",
            "title": "Prospective study evaluating the use of nasal glucagon for the treatment of moderate to severe hypoglycaemia in adults with type 1 diabetes in a real-world setting.",
            "url": "https://pubmed.ncbi.nlm.nih.gov/29504662/"
          }
        ]
      }
    },
    {
      "id": "living-review-ipamorelin-v1-published",
      "url": "https://peptidescanner.com/peptides/ipamorelin/synthesis/versions/1/",
      "title": "Ipamorelin Human Evidence Review version 1",
      "content_text": "PeptideScanner published bounded review version 1 from 2 explicitly reviewed source snapshots.",
      "date_published": "2026-09-15T00:00:00.000Z",
      "_peptidescanner": {
        "id": "living-review-ipamorelin-v1-published",
        "kind": "review-version-published",
        "peptideSlug": "ipamorelin",
        "peptideName": "Ipamorelin",
        "version": 1,
        "changedAt": "2026-09-15",
        "integrityCheckedAt": null,
        "sourceChangedAt": null,
        "title": "Ipamorelin Human Evidence Review version 1",
        "summary": "PeptideScanner published bounded review version 1 from 2 explicitly reviewed source snapshots.",
        "href": "/peptides/ipamorelin/synthesis/versions/1/",
        "citations": [
          {
            "authority": "PubMed",
            "recordId": "25331030",
            "title": "Prospective, randomized, controlled, proof-of-concept study of the Ghrelin mimetic ipamorelin for the management of postoperative ileus in bowel resection patients.",
            "url": "https://pubmed.ncbi.nlm.nih.gov/25331030/"
          },
          {
            "authority": "PubMed",
            "recordId": "10496658",
            "title": "Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers.",
            "url": "https://pubmed.ncbi.nlm.nih.gov/10496658/"
          }
        ]
      }
    },
    {
      "id": "living-review-ipamorelin-v2-published",
      "url": "https://peptidescanner.com/peptides/ipamorelin/synthesis/versions/2/",
      "title": "Ipamorelin Human Evidence Review version 2",
      "content_text": "PeptideScanner published bounded review version 2 from 4 explicitly reviewed source snapshots.",
      "date_published": "2026-09-15T00:00:00.000Z",
      "_peptidescanner": {
        "id": "living-review-ipamorelin-v2-published",
        "kind": "review-version-published",
        "peptideSlug": "ipamorelin",
        "peptideName": "Ipamorelin",
        "version": 2,
        "changedAt": "2026-09-15",
        "integrityCheckedAt": null,
        "sourceChangedAt": null,
        "title": "Ipamorelin Human Evidence Review version 2",
        "summary": "PeptideScanner published bounded review version 2 from 4 explicitly reviewed source snapshots.",
        "href": "/peptides/ipamorelin/synthesis/versions/2/",
        "citations": [
          {
            "authority": "PubMed",
            "recordId": "25331030",
            "title": "Prospective, randomized, controlled, proof-of-concept study of the Ghrelin mimetic ipamorelin for the management of postoperative ileus in bowel resection patients.",
            "url": "https://pubmed.ncbi.nlm.nih.gov/25331030/"
          },
          {
            "authority": "PubMed",
            "recordId": "10496658",
            "title": "Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers.",
            "url": "https://pubmed.ncbi.nlm.nih.gov/10496658/"
          },
          {
            "authority": "PubMed",
            "recordId": "25869809",
            "title": "Determination of growth hormone releasing peptides metabolites in human urine after nasal administration of GHRP-1, GHRP-2, GHRP-6, Hexarelin, and Ipamorelin.",
            "url": "https://pubmed.ncbi.nlm.nih.gov/25869809/"
          },
          {
            "authority": "PubMed",
            "recordId": "26811125",
            "title": "Structure-activity relationship for peptídic growth hormone secretagogues.",
            "url": "https://pubmed.ncbi.nlm.nih.gov/26811125/"
          }
        ]
      }
    },
    {
      "id": "living-review-lanreotide-v1-published",
      "url": "https://peptidescanner.com/peptides/lanreotide/synthesis/versions/1/",
      "title": "Lanreotide Human Evidence Review version 1",
      "content_text": "PeptideScanner published bounded review version 1 from 3 explicitly reviewed source snapshots.",
      "date_published": "2026-09-15T00:00:00.000Z",
      "_peptidescanner": {
        "id": "living-review-lanreotide-v1-published",
        "kind": "review-version-published",
        "peptideSlug": "lanreotide",
        "peptideName": "Lanreotide",
        "version": 1,
        "changedAt": "2026-09-15",
        "integrityCheckedAt": null,
        "sourceChangedAt": null,
        "title": "Lanreotide Human Evidence Review version 1",
        "summary": "PeptideScanner published bounded review version 1 from 3 explicitly reviewed source snapshots.",
        "href": "/peptides/lanreotide/synthesis/versions/1/",
        "citations": [
          {
            "authority": "PubMed",
            "recordId": "25014687",
            "title": "Lanreotide in metastatic enteropancreatic neuroendocrine tumors.",
            "url": "https://pubmed.ncbi.nlm.nih.gov/25014687/"
          },
          {
            "authority": "PubMed",
            "recordId": "33052555",
            "title": "Lanreotide autogel/depot in advanced enteropancreatic neuroendocrine tumours: final results of the CLARINET open-label extension study.",
            "url": "https://pubmed.ncbi.nlm.nih.gov/33052555/"
          },
          {
            "authority": "PubMed",
            "recordId": "24423301",
            "title": "Tumor shrinkage with lanreotide Autogel 120 mg as primary therapy in acromegaly: results of a prospective multicenter clinical trial.",
            "url": "https://pubmed.ncbi.nlm.nih.gov/24423301/"
          }
        ]
      }
    },
    {
      "id": "living-review-linaclotide-v1-published",
      "url": "https://peptidescanner.com/peptides/linaclotide/synthesis/versions/1/",
      "title": "Linaclotide Human Evidence Review version 1",
      "content_text": "PeptideScanner published bounded review version 1 from 2 explicitly reviewed source snapshots.",
      "date_published": "2026-09-15T00:00:00.000Z",
      "_peptidescanner": {
        "id": "living-review-linaclotide-v1-published",
        "kind": "review-version-published",
        "peptideSlug": "linaclotide",
        "peptideName": "Linaclotide",
        "version": 1,
        "changedAt": "2026-09-15",
        "integrityCheckedAt": null,
        "sourceChangedAt": null,
        "title": "Linaclotide Human Evidence Review version 1",
        "summary": "PeptideScanner published bounded review version 1 from 2 explicitly reviewed source snapshots.",
        "href": "/peptides/linaclotide/synthesis/versions/1/",
        "citations": [
          {
            "authority": "PubMed",
            "recordId": "21830967",
            "title": "Two randomized trials of linaclotide for chronic constipation.",
            "url": "https://pubmed.ncbi.nlm.nih.gov/21830967/"
          },
          {
            "authority": "PubMed",
            "recordId": "38211604",
            "title": "Efficacy and safety of linaclotide in treating functional constipation in paediatric patients: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial.",
            "url": "https://pubmed.ncbi.nlm.nih.gov/38211604/"
          }
        ]
      }
    },
    {
      "id": "living-review-lixisenatide-v1-published",
      "url": "https://peptidescanner.com/peptides/lixisenatide/synthesis/versions/1/",
      "title": "Lixisenatide Human Evidence Review version 1",
      "content_text": "PeptideScanner published bounded review version 1 from 2 explicitly reviewed source snapshots.",
      "date_published": "2026-09-15T00:00:00.000Z",
      "_peptidescanner": {
        "id": "living-review-lixisenatide-v1-published",
        "kind": "review-version-published",
        "peptideSlug": "lixisenatide",
        "peptideName": "Lixisenatide",
        "version": 1,
        "changedAt": "2026-09-15",
        "integrityCheckedAt": null,
        "sourceChangedAt": null,
        "title": "Lixisenatide Human Evidence Review version 1",
        "summary": "PeptideScanner published bounded review version 1 from 2 explicitly reviewed source snapshots.",
        "href": "/peptides/lixisenatide/synthesis/versions/1/",
        "citations": [
          {
            "authority": "PubMed",
            "recordId": "26630143",
            "title": "Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome.",
            "url": "https://pubmed.ncbi.nlm.nih.gov/26630143/"
          },
          {
            "authority": "PubMed",
            "recordId": "38598572",
            "title": "Trial of Lixisenatide in Early Parkinson's Disease.",
            "url": "https://pubmed.ncbi.nlm.nih.gov/38598572/"
          }
        ]
      }
    },
    {
      "id": "living-review-maridebart-cafraglutide-v1-published",
      "url": "https://peptidescanner.com/peptides/maridebart-cafraglutide/synthesis/versions/1/",
      "title": "Maridebart cafraglutide Human Evidence Review version 1",
      "content_text": "PeptideScanner published bounded review version 1 from 2 explicitly reviewed source snapshots.",
      "date_published": "2026-09-15T00:00:00.000Z",
      "_peptidescanner": {
        "id": "living-review-maridebart-cafraglutide-v1-published",
        "kind": "review-version-published",
        "peptideSlug": "maridebart-cafraglutide",
        "peptideName": "Maridebart cafraglutide",
        "version": 1,
        "changedAt": "2026-09-15",
        "integrityCheckedAt": null,
        "sourceChangedAt": null,
        "title": "Maridebart cafraglutide Human Evidence Review version 1",
        "summary": "PeptideScanner published bounded review version 1 from 2 explicitly reviewed source snapshots.",
        "href": "/peptides/maridebart-cafraglutide/synthesis/versions/1/",
        "citations": [
          {
            "authority": "PubMed",
            "recordId": "38316982",
            "title": "A GIPR antagonist conjugated to GLP-1 analogues promotes weight loss with improved metabolic parameters in preclinical and phase 1 settings.",
            "url": "https://pubmed.ncbi.nlm.nih.gov/38316982/"
          },
          {
            "authority": "PubMed",
            "recordId": "40549887",
            "title": "Once-Monthly Maridebart Cafraglutide for the Treatment of Obesity - A Phase 2 Trial.",
            "url": "https://pubmed.ncbi.nlm.nih.gov/40549887/"
          }
        ]
      }
    },
    {
      "id": "living-review-mazdutide-v1-published",
      "url": "https://peptidescanner.com/peptides/mazdutide/synthesis/versions/1/",
      "title": "Mazdutide Human Evidence Review version 1",
      "content_text": "PeptideScanner published bounded review version 1 from 4 explicitly reviewed source snapshots.",
      "date_published": "2026-09-15T00:00:00.000Z",
      "_peptidescanner": {
        "id": "living-review-mazdutide-v1-published",
        "kind": "review-version-published",
        "peptideSlug": "mazdutide",
        "peptideName": "Mazdutide",
        "version": 1,
        "changedAt": "2026-09-15",
        "integrityCheckedAt": null,
        "sourceChangedAt": null,
        "title": "Mazdutide Human Evidence Review version 1",
        "summary": "PeptideScanner published bounded review version 1 from 4 explicitly reviewed source snapshots.",
        "href": "/peptides/mazdutide/synthesis/versions/1/",
        "citations": [
          {
            "authority": "PubMed",
            "recordId": "40421736",
            "title": "Once-Weekly Mazdutide in Chinese Adults with Obesity or Overweight.",
            "url": "https://pubmed.ncbi.nlm.nih.gov/40421736/"
          },
          {
            "authority": "PubMed",
            "recordId": "41407860",
            "title": "Mazdutide versus dulaglutide in Chinese adults with type 2 diabetes.",
            "url": "https://pubmed.ncbi.nlm.nih.gov/41407860/"
          },
          {
            "authority": "PubMed",
            "recordId": "41407859",
            "title": "Mazdutide versus placebo in Chinese adults with type 2 diabetes.",
            "url": "https://pubmed.ncbi.nlm.nih.gov/41407859/"
          },
          {
            "authority": "PubMed",
            "recordId": "42628555",
            "title": "Efficacy and safety of mazdutide in adults with obesity or overweight: a US-based, multicentre, phase 2, randomised, placebo-controlled clinical trial.",
            "url": "https://pubmed.ncbi.nlm.nih.gov/42628555/"
          }
        ]
      }
    },
    {
      "id": "living-review-mots-c-v1-published",
      "url": "https://peptidescanner.com/peptides/mots-c/synthesis/versions/1/",
      "title": "MOTS-c Human Evidence Review version 1",
      "content_text": "PeptideScanner published bounded review version 1 from 3 explicitly reviewed source snapshots.",
      "date_published": "2026-09-15T00:00:00.000Z",
      "_peptidescanner": {
        "id": "living-review-mots-c-v1-published",
        "kind": "review-version-published",
        "peptideSlug": "mots-c",
        "peptideName": "MOTS-c",
        "version": 1,
        "changedAt": "2026-09-15",
        "integrityCheckedAt": null,
        "sourceChangedAt": null,
        "title": "MOTS-c Human Evidence Review version 1",
        "summary": "PeptideScanner published bounded review version 1 from 3 explicitly reviewed source snapshots.",
        "href": "/peptides/mots-c/synthesis/versions/1/",
        "citations": [
          {
            "authority": "PubMed",
            "recordId": "34351816",
            "title": "Acute endurance exercise stimulates circulating levels of mitochondrial-derived peptides in humans.",
            "url": "https://pubmed.ncbi.nlm.nih.gov/34351816/"
          },
          {
            "authority": "PubMed",
            "recordId": "34413391",
            "title": "Effect of aerobic and resistance exercise on the mitochondrial peptide MOTS-c in Hispanic and Non-Hispanic White breast cancer survivors.",
            "url": "https://pubmed.ncbi.nlm.nih.gov/34413391/"
          },
          {
            "authority": "PubMed",
            "recordId": "29242099",
            "title": "Downregulation of circulating MOTS-c levels in patients with coronary endothelial dysfunction.",
            "url": "https://pubmed.ncbi.nlm.nih.gov/29242099/"
          }
        ]
      }
    },
    {
      "id": "living-review-pemvidutide-v1-published",
      "url": "https://peptidescanner.com/peptides/pemvidutide/synthesis/versions/1/",
      "title": "Pemvidutide Human Evidence Review version 1",
      "content_text": "PeptideScanner published bounded review version 1 from 2 explicitly reviewed source snapshots.",
      "date_published": "2026-09-15T00:00:00.000Z",
      "_peptidescanner": {
        "id": "living-review-pemvidutide-v1-published",
        "kind": "review-version-published",
        "peptideSlug": "pemvidutide",
        "peptideName": "Pemvidutide",
        "version": 1,
        "changedAt": "2026-09-15",
        "integrityCheckedAt": null,
        "sourceChangedAt": null,
        "title": "Pemvidutide Human Evidence Review version 1",
        "summary": "PeptideScanner published bounded review version 1 from 2 explicitly reviewed source snapshots.",
        "href": "/peptides/pemvidutide/synthesis/versions/1/",
        "citations": [
          {
            "authority": "PubMed",
            "recordId": "41113119",
            "title": "Safety and efficacy of 24 weeks of pemvidutide in metabolic dysfunction-associated steatotic liver disease: A randomized, controlled clinical trial.",
            "url": "https://pubmed.ncbi.nlm.nih.gov/41113119/"
          },
          {
            "authority": "PubMed",
            "recordId": "41237796",
            "title": "Safety and efficacy of weekly pemvidutide versus placebo for metabolic dysfunction-associated steatohepatitis (IMPACT): 24-week results from a multicentre, randomised, double-blind, phase 2b study.",
            "url": "https://pubmed.ncbi.nlm.nih.gov/41237796/"
          }
        ]
      }
    },
    {
      "id": "living-review-petrelintide-v1-published",
      "url": "https://peptidescanner.com/peptides/petrelintide/synthesis/versions/1/",
      "title": "Petrelintide Human Evidence Review version 1",
      "content_text": "PeptideScanner published bounded review version 1 from 1 explicitly reviewed source snapshot.",
      "date_published": "2026-09-15T00:00:00.000Z",
      "_peptidescanner": {
        "id": "living-review-petrelintide-v1-published",
        "kind": "review-version-published",
        "peptideSlug": "petrelintide",
        "peptideName": "Petrelintide",
        "version": 1,
        "changedAt": "2026-09-15",
        "integrityCheckedAt": null,
        "sourceChangedAt": null,
        "title": "Petrelintide Human Evidence Review version 1",
        "summary": "PeptideScanner published bounded review version 1 from 1 explicitly reviewed source snapshot.",
        "href": "/peptides/petrelintide/synthesis/versions/1/",
        "citations": [
          {
            "authority": "PubMed",
            "recordId": "42017294",
            "title": "Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Petrelintide for Weight Management: Two Randomized, Controlled Phase 1 Trials.",
            "url": "https://pubmed.ncbi.nlm.nih.gov/42017294/"
          }
        ]
      }
    },
    {
      "id": "living-review-plecanatide-v1-published",
      "url": "https://peptidescanner.com/peptides/plecanatide/synthesis/versions/1/",
      "title": "Plecanatide Human Evidence Review version 1",
      "content_text": "PeptideScanner published bounded review version 1 from 3 explicitly reviewed source snapshots.",
      "date_published": "2026-09-15T00:00:00.000Z",
      "_peptidescanner": {
        "id": "living-review-plecanatide-v1-published",
        "kind": "review-version-published",
        "peptideSlug": "plecanatide",
        "peptideName": "Plecanatide",
        "version": 1,
        "changedAt": "2026-09-15",
        "integrityCheckedAt": null,
        "sourceChangedAt": null,
        "title": "Plecanatide Human Evidence Review version 1",
        "summary": "PeptideScanner published bounded review version 1 from 3 explicitly reviewed source snapshots.",
        "href": "/peptides/plecanatide/synthesis/versions/1/",
        "citations": [
          {
            "authority": "PubMed",
            "recordId": "28169285",
            "title": "A Randomized Phase III Clinical Trial of Plecanatide, a Uroguanylin Analog, in Patients With Chronic Idiopathic Constipation.",
            "url": "https://pubmed.ncbi.nlm.nih.gov/28169285/"
          },
          {
            "authority": "PubMed",
            "recordId": "29147135",
            "title": "Randomized clinical trial: efficacy and safety of plecanatide in the treatment of chronic idiopathic constipation.",
            "url": "https://pubmed.ncbi.nlm.nih.gov/29147135/"
          },
          {
            "authority": "PubMed",
            "recordId": "29545635",
            "title": "Efficacy, safety, and tolerability of plecanatide in patients with irritable bowel syndrome with constipation: results of two phase 3 randomized clinical trials.",
            "url": "https://pubmed.ncbi.nlm.nih.gov/29545635/"
          }
        ]
      }
    },
    {
      "id": "living-review-pramlintide-v1-published",
      "url": "https://peptidescanner.com/peptides/pramlintide/synthesis/versions/1/",
      "title": "Pramlintide Human Evidence Review version 1",
      "content_text": "PeptideScanner published bounded review version 1 from 3 explicitly reviewed source snapshots.",
      "date_published": "2026-09-15T00:00:00.000Z",
      "_peptidescanner": {
        "id": "living-review-pramlintide-v1-published",
        "kind": "review-version-published",
        "peptideSlug": "pramlintide",
        "peptideName": "Pramlintide",
        "version": 1,
        "changedAt": "2026-09-15",
        "integrityCheckedAt": null,
        "sourceChangedAt": null,
        "title": "Pramlintide Human Evidence Review version 1",
        "summary": "PeptideScanner published bounded review version 1 from 3 explicitly reviewed source snapshots.",
        "href": "/peptides/pramlintide/synthesis/versions/1/",
        "citations": [
          {
            "authority": "PubMed",
            "recordId": "15498087",
            "title": "Amylin replacement with pramlintide as an adjunct to insulin therapy improves long-term glycaemic and weight control in Type 1 diabetes mellitus: a 1-year, randomized controlled trial.",
            "url": "https://pubmed.ncbi.nlm.nih.gov/15498087/"
          },
          {
            "authority": "PubMed",
            "recordId": "12610038",
            "title": "Pramlintide as an adjunct to insulin therapy improves long-term glycemic and weight control in patients with type 2 diabetes: a 1-year randomized controlled trial.",
            "url": "https://pubmed.ncbi.nlm.nih.gov/12610038/"
          },
          {
            "authority": "PubMed",
            "recordId": "38906614",
            "title": "Simple meal announcements and pramlintide delivery versus carbohydrate counting in type 1 diabetes with automated fast-acting insulin aspart delivery: a randomised crossover trial in Montreal, Canada.",
            "url": "https://pubmed.ncbi.nlm.nih.gov/38906614/"
          }
        ]
      }
    },
    {
      "id": "living-review-retatrutide-v2-published",
      "url": "https://peptidescanner.com/peptides/retatrutide/synthesis/versions/2/",
      "title": "Retatrutide Human Evidence Review version 2",
      "content_text": "PeptideScanner published bounded review version 2 from 3 explicitly reviewed source snapshots.",
      "date_published": "2026-09-15T00:00:00.000Z",
      "_peptidescanner": {
        "id": "living-review-retatrutide-v2-published",
        "kind": "review-version-published",
        "peptideSlug": "retatrutide",
        "peptideName": "Retatrutide",
        "version": 2,
        "changedAt": "2026-09-15",
        "integrityCheckedAt": null,
        "sourceChangedAt": null,
        "title": "Retatrutide Human Evidence Review version 2",
        "summary": "PeptideScanner published bounded review version 2 from 3 explicitly reviewed source snapshots.",
        "href": "/peptides/retatrutide/synthesis/versions/2/",
        "citations": [
          {
            "authority": "PubMed",
            "recordId": "37366315",
            "title": "Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial",
            "url": "https://pubmed.ncbi.nlm.nih.gov/37366315/"
          },
          {
            "authority": "PubMed",
            "recordId": "37385280",
            "title": "Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA",
            "url": "https://pubmed.ncbi.nlm.nih.gov/37385280/"
          },
          {
            "authority": "PubMed",
            "recordId": "42250575",
            "title": "Efficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type 2 diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 trial.",
            "url": "https://pubmed.ncbi.nlm.nih.gov/42250575/"
          }
        ]
      }
    },
    {
      "id": "living-review-semax-v1-published",
      "url": "https://peptidescanner.com/peptides/semax/synthesis/versions/1/",
      "title": "Semax Human Evidence Review version 1",
      "content_text": "PeptideScanner published bounded review version 1 from 2 explicitly reviewed source snapshots.",
      "date_published": "2026-09-15T00:00:00.000Z",
      "_peptidescanner": {
        "id": "living-review-semax-v1-published",
        "kind": "review-version-published",
        "peptideSlug": "semax",
        "peptideName": "Semax",
        "version": 1,
        "changedAt": "2026-09-15",
        "integrityCheckedAt": null,
        "sourceChangedAt": null,
        "title": "Semax Human Evidence Review version 1",
        "summary": "PeptideScanner published bounded review version 1 from 2 explicitly reviewed source snapshots.",
        "href": "/peptides/semax/synthesis/versions/1/",
        "citations": [
          {
            "authority": "PubMed",
            "recordId": "29798983",
            "title": "[The efficacy of semax in the tretament of patients at different stages of ischemic stroke].",
            "url": "https://pubmed.ncbi.nlm.nih.gov/29798983/"
          },
          {
            "authority": "PubMed",
            "recordId": "11517472",
            "title": "[Effectiveness of semax in acute period of hemispheric ischemic stroke (a clinical and electrophysiological study)].",
            "url": "https://pubmed.ncbi.nlm.nih.gov/11517472/"
          }
        ]
      }
    },
    {
      "id": "living-review-survodutide-notice-8ce73df73feccfb5-registered",
      "url": "https://peptidescanner.com/peptides/survodutide/synthesis/versions/2/#synthesis-pubmed-42252333-v2",
      "title": "Correction connected to the Survodutide review",
      "content_text": "The reviewed Crossref snapshot attributes this correction notice to publisher metadata. It is not a PeptideScanner correction.",
      "date_published": "2026-09-15T00:00:00.000Z",
      "_peptidescanner": {
        "id": "living-review-survodutide-notice-8ce73df73feccfb5-registered",
        "kind": "publisher-notice-registered",
        "peptideSlug": "survodutide",
        "peptideName": "Survodutide",
        "version": 2,
        "changedAt": "2026-09-15",
        "integrityCheckedAt": "2026-09-15",
        "sourceChangedAt": "2026-08-25",
        "title": "Correction connected to the Survodutide review",
        "summary": "The reviewed Crossref snapshot attributes this correction notice to publisher metadata. It is not a PeptideScanner correction.",
        "href": "/peptides/survodutide/synthesis/versions/2/#synthesis-pubmed-42252333-v2",
        "citations": [
          {
            "authority": "PubMed",
            "recordId": "42252333",
            "title": "Survodutide in adults with obesity and metabolic dysfunction-associated steatotic liver disease: SYNCHRONIZE-MASLD, a randomized, double-blind, placebo-controlled phase 3 trial.",
            "url": "https://pubmed.ncbi.nlm.nih.gov/42252333/"
          },
          {
            "authority": "Crossref",
            "recordId": "10.1038/s41591-026-04479-3",
            "title": "Crossref integrity metadata for PMID 42252333",
            "url": "https://api.crossref.org/works/10.1038%2Fs41591-026-04479-3"
          },
          {
            "authority": "DOI",
            "recordId": "10.1038/s41591-026-04650-w",
            "title": "Correction",
            "url": "https://doi.org/10.1038/s41591-026-04650-w"
          }
        ]
      }
    },
    {
      "id": "living-review-survodutide-v2-published",
      "url": "https://peptidescanner.com/peptides/survodutide/synthesis/versions/2/",
      "title": "Survodutide Human Evidence Review version 2",
      "content_text": "PeptideScanner published bounded review version 2 from 4 explicitly reviewed source snapshots.",
      "date_published": "2026-09-15T00:00:00.000Z",
      "_peptidescanner": {
        "id": "living-review-survodutide-v2-published",
        "kind": "review-version-published",
        "peptideSlug": "survodutide",
        "peptideName": "Survodutide",
        "version": 2,
        "changedAt": "2026-09-15",
        "integrityCheckedAt": null,
        "sourceChangedAt": null,
        "title": "Survodutide Human Evidence Review version 2",
        "summary": "PeptideScanner published bounded review version 2 from 4 explicitly reviewed source snapshots.",
        "href": "/peptides/survodutide/synthesis/versions/2/",
        "citations": [
          {
            "authority": "PubMed",
            "recordId": "38330987",
            "title": "Glucagon and GLP-1 receptor dual agonist survodutide for obesity: a randomised, double-blind, placebo-controlled, dose-finding phase 2 trial",
            "url": "https://pubmed.ncbi.nlm.nih.gov/38330987/"
          },
          {
            "authority": "PubMed",
            "recordId": "38847460",
            "title": "A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis",
            "url": "https://pubmed.ncbi.nlm.nih.gov/38847460/"
          },
          {
            "authority": "PubMed",
            "recordId": "42253238",
            "title": "Survodutide Once Weekly for the Treatment of Adults with Obesity.",
            "url": "https://pubmed.ncbi.nlm.nih.gov/42253238/"
          },
          {
            "authority": "PubMed",
            "recordId": "42252333",
            "title": "Survodutide in adults with obesity and metabolic dysfunction-associated steatotic liver disease: SYNCHRONIZE-MASLD, a randomized, double-blind, placebo-controlled phase 3 trial.",
            "url": "https://pubmed.ncbi.nlm.nih.gov/42252333/"
          }
        ]
      }
    },
    {
      "id": "living-review-ziconotide-v1-published",
      "url": "https://peptidescanner.com/peptides/ziconotide/synthesis/versions/1/",
      "title": "Ziconotide Human Evidence Review version 1",
      "content_text": "PeptideScanner published bounded review version 1 from 3 explicitly reviewed source snapshots.",
      "date_published": "2026-09-15T00:00:00.000Z",
      "_peptidescanner": {
        "id": "living-review-ziconotide-v1-published",
        "kind": "review-version-published",
        "peptideSlug": "ziconotide",
        "peptideName": "Ziconotide",
        "version": 1,
        "changedAt": "2026-09-15",
        "integrityCheckedAt": null,
        "sourceChangedAt": null,
        "title": "Ziconotide Human Evidence Review version 1",
        "summary": "PeptideScanner published bounded review version 1 from 3 explicitly reviewed source snapshots.",
        "href": "/peptides/ziconotide/synthesis/versions/1/",
        "citations": [
          {
            "authority": "PubMed",
            "recordId": "16716870",
            "title": "A randomized, double-blind, placebo-controlled study of intrathecal ziconotide in adults with severe chronic pain.",
            "url": "https://pubmed.ncbi.nlm.nih.gov/16716870/"
          },
          {
            "authority": "PubMed",
            "recordId": "14709577",
            "title": "Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: a randomized controlled trial.",
            "url": "https://pubmed.ncbi.nlm.nih.gov/14709577/"
          },
          {
            "authority": "PubMed",
            "recordId": "22151630",
            "title": "Intrathecal ziconotide in the treatment of chronic nonmalignant pain: a randomized, double-blind, placebo-controlled clinical trial.",
            "url": "https://pubmed.ncbi.nlm.nih.gov/22151630/"
          }
        ]
      }
    },
    {
      "id": "living-review-abaloparatide-v1-published",
      "url": "https://peptidescanner.com/peptides/abaloparatide/synthesis/versions/1/",
      "title": "Abaloparatide Human Evidence Review version 1",
      "content_text": "PeptideScanner published bounded review version 1 from 3 explicitly reviewed source snapshots.",
      "date_published": "2026-09-14T00:00:00.000Z",
      "_peptidescanner": {
        "id": "living-review-abaloparatide-v1-published",
        "kind": "review-version-published",
        "peptideSlug": "abaloparatide",
        "peptideName": "Abaloparatide",
        "version": 1,
        "changedAt": "2026-09-14",
        "integrityCheckedAt": null,
        "sourceChangedAt": null,
        "title": "Abaloparatide Human Evidence Review version 1",
        "summary": "PeptideScanner published bounded review version 1 from 3 explicitly reviewed source snapshots.",
        "href": "/peptides/abaloparatide/synthesis/versions/1/",
        "citations": [
          {
            "authority": "PubMed",
            "recordId": "27533157",
            "title": "Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis: A Randomized Clinical Trial",
            "url": "https://pubmed.ncbi.nlm.nih.gov/27533157/"
          },
          {
            "authority": "PubMed",
            "recordId": "29800372",
            "title": "ACTIVExtend: 24 Months of Alendronate After 18 Months of Abaloparatide or Placebo for Postmenopausal Osteoporosis",
            "url": "https://pubmed.ncbi.nlm.nih.gov/29800372/"
          },
          {
            "authority": "PubMed",
            "recordId": "36190391",
            "title": "The Efficacy and Safety of Abaloparatide-SC in Men With Osteoporosis: A Randomized Clinical Trial",
            "url": "https://pubmed.ncbi.nlm.nih.gov/36190391/"
          }
        ]
      }
    },
    {
      "id": "living-review-cagrilintide-v1-published",
      "url": "https://peptidescanner.com/peptides/cagrilintide/synthesis/versions/1/",
      "title": "Cagrilintide Human Evidence Review version 1",
      "content_text": "PeptideScanner published bounded review version 1 from 1 explicitly reviewed source snapshot.",
      "date_published": "2026-08-19T00:00:00.000Z",
      "_peptidescanner": {
        "id": "living-review-cagrilintide-v1-published",
        "kind": "review-version-published",
        "peptideSlug": "cagrilintide",
        "peptideName": "Cagrilintide",
        "version": 1,
        "changedAt": "2026-08-19",
        "integrityCheckedAt": null,
        "sourceChangedAt": null,
        "title": "Cagrilintide Human Evidence Review version 1",
        "summary": "PeptideScanner published bounded review version 1 from 1 explicitly reviewed source snapshot.",
        "href": "/peptides/cagrilintide/synthesis/versions/1/",
        "citations": [
          {
            "authority": "PubMed",
            "recordId": "34798060",
            "title": "Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial",
            "url": "https://pubmed.ncbi.nlm.nih.gov/34798060/"
          }
        ]
      }
    },
    {
      "id": "living-review-exenatide-v1-published",
      "url": "https://peptidescanner.com/peptides/exenatide/synthesis/versions/1/",
      "title": "Exenatide Human Evidence Review version 1",
      "content_text": "PeptideScanner published bounded review version 1 from 2 explicitly reviewed source snapshots.",
      "date_published": "2026-08-19T00:00:00.000Z",
      "_peptidescanner": {
        "id": "living-review-exenatide-v1-published",
        "kind": "review-version-published",
        "peptideSlug": "exenatide",
        "peptideName": "Exenatide",
        "version": 1,
        "changedAt": "2026-08-19",
        "integrityCheckedAt": null,
        "sourceChangedAt": null,
        "title": "Exenatide Human Evidence Review version 1",
        "summary": "PeptideScanner published bounded review version 1 from 2 explicitly reviewed source snapshots.",
        "href": "/peptides/exenatide/synthesis/versions/1/",
        "citations": [
          {
            "authority": "PubMed",
            "recordId": "28910237",
            "title": "Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes",
            "url": "https://pubmed.ncbi.nlm.nih.gov/28910237/"
          },
          {
            "authority": "PubMed",
            "recordId": "18803987",
            "title": "Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug-naive patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, parallel-group study",
            "url": "https://pubmed.ncbi.nlm.nih.gov/18803987/"
          }
        ]
      }
    },
    {
      "id": "living-review-leuprolide-v1-published",
      "url": "https://peptidescanner.com/peptides/leuprolide/synthesis/versions/1/",
      "title": "Leuprolide Human Evidence Review version 1",
      "content_text": "PeptideScanner published bounded review version 1 from 2 explicitly reviewed source snapshots.",
      "date_published": "2026-08-19T00:00:00.000Z",
      "_peptidescanner": {
        "id": "living-review-leuprolide-v1-published",
        "kind": "review-version-published",
        "peptideSlug": "leuprolide",
        "peptideName": "Leuprolide",
        "version": 1,
        "changedAt": "2026-08-19",
        "integrityCheckedAt": null,
        "sourceChangedAt": null,
        "title": "Leuprolide Human Evidence Review version 1",
        "summary": "PeptideScanner published bounded review version 1 from 2 explicitly reviewed source snapshots.",
        "href": "/peptides/leuprolide/synthesis/versions/1/",
        "citations": [
          {
            "authority": "PubMed",
            "recordId": "21300339",
            "title": "Randomized trial of leuprolide versus continuous oral contraceptives in the treatment of endometriosis-associated pelvic pain",
            "url": "https://pubmed.ncbi.nlm.nih.gov/21300339/"
          },
          {
            "authority": "PubMed",
            "recordId": "32469183",
            "title": "Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer",
            "url": "https://pubmed.ncbi.nlm.nih.gov/32469183/"
          }
        ]
      }
    },
    {
      "id": "living-review-liraglutide-v1-published",
      "url": "https://peptidescanner.com/peptides/liraglutide/synthesis/versions/1/",
      "title": "Liraglutide Human Evidence Review version 1",
      "content_text": "PeptideScanner published bounded review version 1 from 2 explicitly reviewed source snapshots.",
      "date_published": "2026-08-19T00:00:00.000Z",
      "_peptidescanner": {
        "id": "living-review-liraglutide-v1-published",
        "kind": "review-version-published",
        "peptideSlug": "liraglutide",
        "peptideName": "Liraglutide",
        "version": 1,
        "changedAt": "2026-08-19",
        "integrityCheckedAt": null,
        "sourceChangedAt": null,
        "title": "Liraglutide Human Evidence Review version 1",
        "summary": "PeptideScanner published bounded review version 1 from 2 explicitly reviewed source snapshots.",
        "href": "/peptides/liraglutide/synthesis/versions/1/",
        "citations": [
          {
            "authority": "PubMed",
            "recordId": "26132939",
            "title": "A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management",
            "url": "https://pubmed.ncbi.nlm.nih.gov/26132939/"
          },
          {
            "authority": "PubMed",
            "recordId": "27295427",
            "title": "Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes",
            "url": "https://pubmed.ncbi.nlm.nih.gov/27295427/"
          }
        ]
      }
    },
    {
      "id": "living-review-octreotide-notice-a8b50863f682ea49-registered",
      "url": "https://peptidescanner.com/peptides/octreotide/synthesis/versions/1/#synthesis-pubmed-34953531-v1",
      "title": "Erratum connected to the Octreotide review",
      "content_text": "The reviewed Crossref snapshot attributes this erratum notice to publisher metadata. It is not a PeptideScanner correction.",
      "date_published": "2026-08-19T00:00:00.000Z",
      "_peptidescanner": {
        "id": "living-review-octreotide-notice-a8b50863f682ea49-registered",
        "kind": "publisher-notice-registered",
        "peptideSlug": "octreotide",
        "peptideName": "Octreotide",
        "version": 1,
        "changedAt": "2026-08-19",
        "integrityCheckedAt": "2026-08-19",
        "sourceChangedAt": "2022-03-01",
        "title": "Erratum connected to the Octreotide review",
        "summary": "The reviewed Crossref snapshot attributes this erratum notice to publisher metadata. It is not a PeptideScanner correction.",
        "href": "/peptides/octreotide/synthesis/versions/1/#synthesis-pubmed-34953531-v1",
        "citations": [
          {
            "authority": "PubMed",
            "recordId": "34953531",
            "title": "Maintenance of response to oral octreotide compared with injectable somatostatin receptor ligands in patients with acromegaly: a phase 3, multicentre, randomised controlled trial",
            "url": "https://pubmed.ncbi.nlm.nih.gov/34953531/"
          },
          {
            "authority": "Crossref",
            "recordId": "10.1016/s2213-8587(21)00296-5",
            "title": "Crossref integrity metadata for PMID 34953531",
            "url": "https://api.crossref.org/works/10.1016%2Fs2213-8587(21)00296-5"
          },
          {
            "authority": "DOI",
            "recordId": "10.1016/s2213-8587(22)00051-1",
            "title": "Erratum",
            "url": "https://doi.org/10.1016/s2213-8587(22)00051-1"
          }
        ]
      }
    },
    {
      "id": "living-review-octreotide-v1-published",
      "url": "https://peptidescanner.com/peptides/octreotide/synthesis/versions/1/",
      "title": "Octreotide Human Evidence Review version 1",
      "content_text": "PeptideScanner published bounded review version 1 from 2 explicitly reviewed source snapshots.",
      "date_published": "2026-08-19T00:00:00.000Z",
      "_peptidescanner": {
        "id": "living-review-octreotide-v1-published",
        "kind": "review-version-published",
        "peptideSlug": "octreotide",
        "peptideName": "Octreotide",
        "version": 1,
        "changedAt": "2026-08-19",
        "integrityCheckedAt": null,
        "sourceChangedAt": null,
        "title": "Octreotide Human Evidence Review version 1",
        "summary": "PeptideScanner published bounded review version 1 from 2 explicitly reviewed source snapshots.",
        "href": "/peptides/octreotide/synthesis/versions/1/",
        "citations": [
          {
            "authority": "PubMed",
            "recordId": "2229278",
            "title": "Short term treatment of acromegaly with the somatostatin analog octreotide: the first double-blind randomized placebo-controlled study on its effects",
            "url": "https://pubmed.ncbi.nlm.nih.gov/2229278/"
          },
          {
            "authority": "PubMed",
            "recordId": "34953531",
            "title": "Maintenance of response to oral octreotide compared with injectable somatostatin receptor ligands in patients with acromegaly: a phase 3, multicentre, randomised controlled trial",
            "url": "https://pubmed.ncbi.nlm.nih.gov/34953531/"
          }
        ]
      }
    },
    {
      "id": "living-review-setmelanotide-notice-c40e62f6868127ec-registered",
      "url": "https://peptidescanner.com/peptides/setmelanotide/synthesis/versions/1/#synthesis-pubmed-36356613-v1",
      "title": "Erratum connected to the Setmelanotide review",
      "content_text": "The reviewed Crossref snapshot attributes this erratum notice to publisher metadata. It is not a PeptideScanner correction.",
      "date_published": "2026-08-19T00:00:00.000Z",
      "_peptidescanner": {
        "id": "living-review-setmelanotide-notice-c40e62f6868127ec-registered",
        "kind": "publisher-notice-registered",
        "peptideSlug": "setmelanotide",
        "peptideName": "Setmelanotide",
        "version": 1,
        "changedAt": "2026-08-19",
        "integrityCheckedAt": "2026-08-19",
        "sourceChangedAt": "2023-02-01",
        "title": "Erratum connected to the Setmelanotide review",
        "summary": "The reviewed Crossref snapshot attributes this erratum notice to publisher metadata. It is not a PeptideScanner correction.",
        "href": "/peptides/setmelanotide/synthesis/versions/1/#synthesis-pubmed-36356613-v1",
        "citations": [
          {
            "authority": "PubMed",
            "recordId": "36356613",
            "title": "Efficacy and safety of setmelanotide, a melanocortin-4 receptor agonist, in patients with Bardet-Biedl syndrome and Alström syndrome: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial with an open-label period",
            "url": "https://pubmed.ncbi.nlm.nih.gov/36356613/"
          },
          {
            "authority": "Crossref",
            "recordId": "10.1016/s2213-8587(22)00277-7",
            "title": "Crossref integrity metadata for PMID 36356613",
            "url": "https://api.crossref.org/works/10.1016%2Fs2213-8587(22)00277-7"
          },
          {
            "authority": "DOI",
            "recordId": "10.1016/s2213-8587(22)00360-6",
            "title": "Erratum",
            "url": "https://doi.org/10.1016/s2213-8587(22)00360-6"
          }
        ]
      }
    },
    {
      "id": "living-review-setmelanotide-v1-published",
      "url": "https://peptidescanner.com/peptides/setmelanotide/synthesis/versions/1/",
      "title": "Setmelanotide Human Evidence Review version 1",
      "content_text": "PeptideScanner published bounded review version 1 from 2 explicitly reviewed source snapshots.",
      "date_published": "2026-08-19T00:00:00.000Z",
      "_peptidescanner": {
        "id": "living-review-setmelanotide-v1-published",
        "kind": "review-version-published",
        "peptideSlug": "setmelanotide",
        "peptideName": "Setmelanotide",
        "version": 1,
        "changedAt": "2026-08-19",
        "integrityCheckedAt": null,
        "sourceChangedAt": null,
        "title": "Setmelanotide Human Evidence Review version 1",
        "summary": "PeptideScanner published bounded review version 1 from 2 explicitly reviewed source snapshots.",
        "href": "/peptides/setmelanotide/synthesis/versions/1/",
        "citations": [
          {
            "authority": "PubMed",
            "recordId": "33137293",
            "title": "Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials",
            "url": "https://pubmed.ncbi.nlm.nih.gov/33137293/"
          },
          {
            "authority": "PubMed",
            "recordId": "36356613",
            "title": "Efficacy and safety of setmelanotide, a melanocortin-4 receptor agonist, in patients with Bardet-Biedl syndrome and Alström syndrome: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial with an open-label period",
            "url": "https://pubmed.ncbi.nlm.nih.gov/36356613/"
          }
        ]
      }
    },
    {
      "id": "living-review-survodutide-notice-048fbde1fa3ea44e-registered",
      "url": "https://peptidescanner.com/peptides/survodutide/synthesis/versions/1/#synthesis-pubmed-38330987-v1",
      "title": "Erratum connected to the Survodutide review",
      "content_text": "The reviewed Crossref snapshot attributes this erratum notice to publisher metadata. It is not a PeptideScanner correction.",
      "date_published": "2026-08-19T00:00:00.000Z",
      "_peptidescanner": {
        "id": "living-review-survodutide-notice-048fbde1fa3ea44e-registered",
        "kind": "publisher-notice-registered",
        "peptideSlug": "survodutide",
        "peptideName": "Survodutide",
        "version": 1,
        "changedAt": "2026-08-19",
        "integrityCheckedAt": "2026-08-19",
        "sourceChangedAt": "2026-02-01",
        "title": "Erratum connected to the Survodutide review",
        "summary": "The reviewed Crossref snapshot attributes this erratum notice to publisher metadata. It is not a PeptideScanner correction.",
        "href": "/peptides/survodutide/synthesis/versions/1/#synthesis-pubmed-38330987-v1",
        "citations": [
          {
            "authority": "PubMed",
            "recordId": "38330987",
            "title": "Glucagon and GLP-1 receptor dual agonist survodutide for obesity: a randomised, double-blind, placebo-controlled, dose-finding phase 2 trial",
            "url": "https://pubmed.ncbi.nlm.nih.gov/38330987/"
          },
          {
            "authority": "Crossref",
            "recordId": "10.1016/s2213-8587(23)00356-x",
            "title": "Crossref integrity metadata for PMID 38330987",
            "url": "https://api.crossref.org/works/10.1016%2Fs2213-8587(23)00356-x"
          },
          {
            "authority": "DOI",
            "recordId": "10.1016/s2213-8587(25)00399-7",
            "title": "Erratum",
            "url": "https://doi.org/10.1016/s2213-8587(25)00399-7"
          }
        ]
      }
    },
    {
      "id": "living-review-survodutide-v1-published",
      "url": "https://peptidescanner.com/peptides/survodutide/synthesis/versions/1/",
      "title": "Survodutide Human Evidence Review version 1",
      "content_text": "PeptideScanner published bounded review version 1 from 2 explicitly reviewed source snapshots.",
      "date_published": "2026-08-19T00:00:00.000Z",
      "_peptidescanner": {
        "id": "living-review-survodutide-v1-published",
        "kind": "review-version-published",
        "peptideSlug": "survodutide",
        "peptideName": "Survodutide",
        "version": 1,
        "changedAt": "2026-08-19",
        "integrityCheckedAt": null,
        "sourceChangedAt": null,
        "title": "Survodutide Human Evidence Review version 1",
        "summary": "PeptideScanner published bounded review version 1 from 2 explicitly reviewed source snapshots.",
        "href": "/peptides/survodutide/synthesis/versions/1/",
        "citations": [
          {
            "authority": "PubMed",
            "recordId": "38330987",
            "title": "Glucagon and GLP-1 receptor dual agonist survodutide for obesity: a randomised, double-blind, placebo-controlled, dose-finding phase 2 trial",
            "url": "https://pubmed.ncbi.nlm.nih.gov/38330987/"
          },
          {
            "authority": "PubMed",
            "recordId": "38847460",
            "title": "A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis",
            "url": "https://pubmed.ncbi.nlm.nih.gov/38847460/"
          }
        ]
      }
    },
    {
      "id": "living-review-teriparatide-v1-published",
      "url": "https://peptidescanner.com/peptides/teriparatide/synthesis/versions/1/",
      "title": "Teriparatide Human Evidence Review version 1",
      "content_text": "PeptideScanner published bounded review version 1 from 2 explicitly reviewed source snapshots.",
      "date_published": "2026-08-19T00:00:00.000Z",
      "_peptidescanner": {
        "id": "living-review-teriparatide-v1-published",
        "kind": "review-version-published",
        "peptideSlug": "teriparatide",
        "peptideName": "Teriparatide",
        "version": 1,
        "changedAt": "2026-08-19",
        "integrityCheckedAt": null,
        "sourceChangedAt": null,
        "title": "Teriparatide Human Evidence Review version 1",
        "summary": "PeptideScanner published bounded review version 1 from 2 explicitly reviewed source snapshots.",
        "href": "/peptides/teriparatide/synthesis/versions/1/",
        "citations": [
          {
            "authority": "PubMed",
            "recordId": "11346808",
            "title": "Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis",
            "url": "https://pubmed.ncbi.nlm.nih.gov/11346808/"
          },
          {
            "authority": "PubMed",
            "recordId": "29129436",
            "title": "Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial",
            "url": "https://pubmed.ncbi.nlm.nih.gov/29129436/"
          }
        ]
      }
    },
    {
      "id": "living-review-tesamorelin-v1-published",
      "url": "https://peptidescanner.com/peptides/tesamorelin/synthesis/versions/1/",
      "title": "Tesamorelin Human Evidence Review version 1",
      "content_text": "PeptideScanner published bounded review version 1 from 2 explicitly reviewed source snapshots.",
      "date_published": "2026-08-19T00:00:00.000Z",
      "_peptidescanner": {
        "id": "living-review-tesamorelin-v1-published",
        "kind": "review-version-published",
        "peptideSlug": "tesamorelin",
        "peptideName": "Tesamorelin",
        "version": 1,
        "changedAt": "2026-08-19",
        "integrityCheckedAt": null,
        "sourceChangedAt": null,
        "title": "Tesamorelin Human Evidence Review version 1",
        "summary": "PeptideScanner published bounded review version 1 from 2 explicitly reviewed source snapshots.",
        "href": "/peptides/tesamorelin/synthesis/versions/1/",
        "citations": [
          {
            "authority": "PubMed",
            "recordId": "18057338",
            "title": "Metabolic effects of a growth hormone-releasing factor in patients with HIV",
            "url": "https://pubmed.ncbi.nlm.nih.gov/18057338/"
          },
          {
            "authority": "PubMed",
            "recordId": "25038357",
            "title": "Effect of tesamorelin on visceral fat and liver fat in HIV-infected patients with abdominal fat accumulation: a randomized clinical trial",
            "url": "https://pubmed.ncbi.nlm.nih.gov/25038357/"
          }
        ]
      }
    },
    {
      "id": "living-review-tirzepatide-notice-b012c11cb738a2dd-registered",
      "url": "https://peptidescanner.com/peptides/tirzepatide/synthesis/versions/1/#synthesis-pubmed-34186022-v1",
      "title": "Erratum connected to the Tirzepatide review",
      "content_text": "The reviewed Crossref snapshot attributes this erratum notice to publisher metadata. It is not a PeptideScanner correction.",
      "date_published": "2026-08-19T00:00:00.000Z",
      "_peptidescanner": {
        "id": "living-review-tirzepatide-notice-b012c11cb738a2dd-registered",
        "kind": "publisher-notice-registered",
        "peptideSlug": "tirzepatide",
        "peptideName": "Tirzepatide",
        "version": 1,
        "changedAt": "2026-08-19",
        "integrityCheckedAt": "2026-08-19",
        "sourceChangedAt": "2021-07-17",
        "title": "Erratum connected to the Tirzepatide review",
        "summary": "The reviewed Crossref snapshot attributes this erratum notice to publisher metadata. It is not a PeptideScanner correction.",
        "href": "/peptides/tirzepatide/synthesis/versions/1/#synthesis-pubmed-34186022-v1",
        "citations": [
          {
            "authority": "PubMed",
            "recordId": "34186022",
            "title": "Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial",
            "url": "https://pubmed.ncbi.nlm.nih.gov/34186022/"
          },
          {
            "authority": "Crossref",
            "recordId": "10.1016/s0140-6736(21)01324-6",
            "title": "Crossref integrity metadata for PMID 34186022",
            "url": "https://api.crossref.org/works/10.1016%2Fs0140-6736(21)01324-6"
          },
          {
            "authority": "DOI",
            "recordId": "10.1016/s0140-6736(21)01556-7",
            "title": "Erratum",
            "url": "https://doi.org/10.1016/s0140-6736(21)01556-7"
          }
        ]
      }
    },
    {
      "id": "living-review-tirzepatide-v1-published",
      "url": "https://peptidescanner.com/peptides/tirzepatide/synthesis/versions/1/",
      "title": "Tirzepatide Human Evidence Review version 1",
      "content_text": "PeptideScanner published bounded review version 1 from 2 explicitly reviewed source snapshots.",
      "date_published": "2026-08-19T00:00:00.000Z",
      "_peptidescanner": {
        "id": "living-review-tirzepatide-v1-published",
        "kind": "review-version-published",
        "peptideSlug": "tirzepatide",
        "peptideName": "Tirzepatide",
        "version": 1,
        "changedAt": "2026-08-19",
        "integrityCheckedAt": null,
        "sourceChangedAt": null,
        "title": "Tirzepatide Human Evidence Review version 1",
        "summary": "PeptideScanner published bounded review version 1 from 2 explicitly reviewed source snapshots.",
        "href": "/peptides/tirzepatide/synthesis/versions/1/",
        "citations": [
          {
            "authority": "PubMed",
            "recordId": "35658024",
            "title": "Tirzepatide Once Weekly for the Treatment of Obesity",
            "url": "https://pubmed.ncbi.nlm.nih.gov/35658024/"
          },
          {
            "authority": "PubMed",
            "recordId": "34186022",
            "title": "Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial",
            "url": "https://pubmed.ncbi.nlm.nih.gov/34186022/"
          }
        ]
      }
    },
    {
      "id": "living-review-bpc-157-v1-published",
      "url": "https://peptidescanner.com/peptides/bpc-157/synthesis/versions/1/",
      "title": "BPC-157 Human Evidence Review version 1",
      "content_text": "PeptideScanner published bounded review version 1 from 3 explicitly reviewed source snapshots.",
      "date_published": "2026-08-18T00:00:00.000Z",
      "_peptidescanner": {
        "id": "living-review-bpc-157-v1-published",
        "kind": "review-version-published",
        "peptideSlug": "bpc-157",
        "peptideName": "BPC-157",
        "version": 1,
        "changedAt": "2026-08-18",
        "integrityCheckedAt": null,
        "sourceChangedAt": null,
        "title": "BPC-157 Human Evidence Review version 1",
        "summary": "PeptideScanner published bounded review version 1 from 3 explicitly reviewed source snapshots.",
        "href": "/peptides/bpc-157/synthesis/versions/1/",
        "citations": [
          {
            "authority": "PubMed",
            "recordId": "40005999",
            "title": "Multifunctionality and Possible Medical Application of the BPC 157 Peptide-Literature and Patent Review",
            "url": "https://pubmed.ncbi.nlm.nih.gov/40005999/"
          },
          {
            "authority": "PubMed",
            "recordId": "40131143",
            "title": "Safety of Intravenous Infusion of BPC157 in Humans: A Pilot Study",
            "url": "https://pubmed.ncbi.nlm.nih.gov/40131143/"
          },
          {
            "authority": "ClinicalTrials.gov",
            "recordId": "NCT07437547",
            "title": "BPC 157 for Acute Hamstring Muscle Strain Repair",
            "url": "https://clinicaltrials.gov/study/NCT07437547?a=1&tab=history"
          }
        ]
      }
    },
    {
      "id": "living-review-retatrutide-v1-published",
      "url": "https://peptidescanner.com/peptides/retatrutide/synthesis/versions/1/",
      "title": "Retatrutide Human Evidence Review version 1",
      "content_text": "PeptideScanner published bounded review version 1 from 2 explicitly reviewed source snapshots.",
      "date_published": "2026-08-18T00:00:00.000Z",
      "_peptidescanner": {
        "id": "living-review-retatrutide-v1-published",
        "kind": "review-version-published",
        "peptideSlug": "retatrutide",
        "peptideName": "Retatrutide",
        "version": 1,
        "changedAt": "2026-08-18",
        "integrityCheckedAt": null,
        "sourceChangedAt": null,
        "title": "Retatrutide Human Evidence Review version 1",
        "summary": "PeptideScanner published bounded review version 1 from 2 explicitly reviewed source snapshots.",
        "href": "/peptides/retatrutide/synthesis/versions/1/",
        "citations": [
          {
            "authority": "PubMed",
            "recordId": "37366315",
            "title": "Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial",
            "url": "https://pubmed.ncbi.nlm.nih.gov/37366315/"
          },
          {
            "authority": "PubMed",
            "recordId": "37385280",
            "title": "Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA",
            "url": "https://pubmed.ncbi.nlm.nih.gov/37385280/"
          }
        ]
      }
    },
    {
      "id": "living-review-semaglutide-v1-published",
      "url": "https://peptidescanner.com/peptides/semaglutide/synthesis/versions/1/",
      "title": "Semaglutide Human Evidence Review version 1",
      "content_text": "PeptideScanner published bounded review version 1 from 2 explicitly reviewed source snapshots.",
      "date_published": "2026-08-18T00:00:00.000Z",
      "_peptidescanner": {
        "id": "living-review-semaglutide-v1-published",
        "kind": "review-version-published",
        "peptideSlug": "semaglutide",
        "peptideName": "Semaglutide",
        "version": 1,
        "changedAt": "2026-08-18",
        "integrityCheckedAt": null,
        "sourceChangedAt": null,
        "title": "Semaglutide Human Evidence Review version 1",
        "summary": "PeptideScanner published bounded review version 1 from 2 explicitly reviewed source snapshots.",
        "href": "/peptides/semaglutide/synthesis/versions/1/",
        "citations": [
          {
            "authority": "PubMed",
            "recordId": "33567185",
            "title": "Once-Weekly Semaglutide in Adults with Overweight or Obesity",
            "url": "https://pubmed.ncbi.nlm.nih.gov/33567185/"
          },
          {
            "authority": "PubMed",
            "recordId": "37952131",
            "title": "Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes",
            "url": "https://pubmed.ncbi.nlm.nih.gov/37952131/"
          }
        ]
      }
    }
  ]
}